Navigation Links
Neurocrine Biosciences Announces elagolix Scientific Presentations at the 11th World Congress on Endometriosis
Date:6/16/2011

SAN DIEGO, June 16, 2011 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that three elagolix presentations have been accepted for the scientific program at 2011 World Congress on Endometriosis, to be held September 4-7, 2011 in Montpellier, France. This important meeting is sponsored by the World Endometriosis Society and occurs every three years, bringing together clinicians and basic scientists from all over the world to share the latest developments in endometriosis.

"We are very pleased to participate in this prestigious scientific event," said Chris O'Brien, MD, Chief Medical Officer at Neurocrine. "This Congress will highlight the marked increase in both the basic science and clinical research related to endometriosis that has occurred in recent years. Endometriosis profoundly impacts the lives of well over one hundred million women worldwide, and global efforts to improve our understanding of the disorder, its symptoms and treatment, are the highlights of this triennial meeting. We are excited to be an integral part of these initiatives and to provide a detailed update on our potential new therapy."

The acceptance of multiple abstracts and datasets from the development program of elagolix for endometriosis at the 2011 World Congress on Endometriosis is as follows:

Data from the recently completed Daisy Petal clinical study of elagolix for the treatment of endometriosis-associated pain will be presented in a speaking session:

  • "Elagolix, A Novel Oral GnRH Antagonist, Significantly Reduced Endometriosis-Associated Pelvic Pain: Results For The Placebo-Controlled, Double-Blind Period Of A Randomized Phase 2 Study" on Wednesday, September 7, 2011 at 10:30 am

Data from the recently completed Daisy Petal clinical study of elagolix for the treatment of endometriosis-associate
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
2. Neurocrine Biosciences Reports First Quarter 2008 Results
3. Neurocrine Biosciences Completes Petal Study Treatment Phase for Endometriosis
4. Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
5. Neurocrine Announces Top-Line Results From 702 Study (Lilac PETAL Study) of Elagolix for Treatment of Endometriosis Pain
6. Neurocrine Biosciences Presents Elagolix Data
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2009 Financial Results
8. Neurocrine Biosciences Reports Third Quarter 2009 Results
9. Neurocrine Advances VMAT2 Inhibitor Program
10. Neurocrine Biosciences to Present at the 21st Annual Piper Jaffray Health Care Conference
11. Neurocrine Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 XRpro ... for drug discovery and development services which features ... the pharmaceutical industry, announced financial results for the ... Timothy C.  Tyson, Chairman of XRpro Sciences commented, ... successfully transition from development stage to commercial stage ...
(Date:3/27/2015)... 27, 2015  Valeant Pharmaceuticals International, Inc. (NYSE: ... its previously announced registered offering of common shares in ... Pursuant to the Offering, the Company issued 7,286,432 common ... aggregate gross proceeds of approximately $1.45 billion. On March ... and Exchange Commission a final prospectus supplement to its ...
(Date:3/27/2015)... NORTH HOLLYWOOD, Calif. , March 27, 2015 /PRNewswire/ ... quality of life of myeloma patients while working toward ... Brian Higgins (D-NY) for introducing a federal resolution ... month of March 2015 as "National Multiple Myeloma Awareness ... people living with myeloma worldwide, and more than 110,000 ...
Breaking Medicine Technology:XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2
... 13, 2011 U.S. Marshals, acting under a court ... on Jan. 5 and 6, seized all dental devices ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... an FDA inspection that found significant deficiencies in the ...
... Although 2010 brought healthcare reform, investors are wondering if ... expect some volatility in the sector, as the Republican-led ... through a repeal effort or withholding funding for portions ... Poor,s Equity Research. "Healthcare reform or ...
Cached Medicine Technology:U.S. Marshals Seize Dental Devices From Florida Manufacturer 2S&P Equity Research Issues Health Care Sector Predictions for 2011 2S&P Equity Research Issues Health Care Sector Predictions for 2011 3S&P Equity Research Issues Health Care Sector Predictions for 2011 4S&P Equity Research Issues Health Care Sector Predictions for 2011 5S&P Equity Research Issues Health Care Sector Predictions for 2011 6
(Date:3/28/2015)... Servpro of Paso Robles , ... a report about the link between mold and asthma. ... according to recent medical research, may even cause asthma ... Environmental Protection Agency, people with sensitivity to mold or ... may trigger asthma attacks for asthma sufferers. The EPA ...
(Date:3/27/2015)... 27, 2015 Florida Hospital is excited to ... team’s exclusive health care provider for the 2015 and 2016 ... provides medical care and an athletic trainer for the team ... off its season against the Cleveland Gladiators at Amalie Arena; ... is extremely important to us as it gives us the ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 Healthpointe is ... G. Katz, M.D., is now treating knee and hip ... Anaheim , Long Beach, and La Mirada. Dr. ... acute knee and hip joint disorders as well as ... is passionate in returning his patients back to their ...
(Date:3/27/2015)... Ticket Down is a reputable source of ... in Omaha, Nebraska on Friday, May 8th and Saturday, May ... will be added in Omaha as Garth has done in ... Garth Brooks World Tour is continuing its run throughout the ... Brooks and Trisha Yearwood will bring their act to Omaha, ...
(Date:3/27/2015)... The report “CountryFocus: Healthcare, Regulatory and Reimbursement ... on and analysis of the healthcare, regulatory and reimbursement ... in 2013 amounted to 316.1 million, having grown at ... 2008. The country’s increasingly elderly population and corresponding increase ... boost the growth of the pharmaceutical market, which was ...
Breaking Medicine News(10 mins):Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 3Health News:Florida Hospital Is Kicking off the 2015 Season as the Exclusive Health Care Provider for the Tampa Bay Storm 2Health News:Florida Hospital Is Kicking off the 2015 Season as the Exclusive Health Care Provider for the Tampa Bay Storm 3Health News:Fellowship-Trained and Board-Certified Orthopedic Surgeon is Now Treating Knee and Hip Joint Disorders in Anaheim, California 2Health News:Fellowship-Trained and Board-Certified Orthopedic Surgeon is Now Treating Knee and Hip Joint Disorders in Anaheim, California 3Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 2Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 3Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 2Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 3Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 4
... exercise combined with nicotine replacement therapy could help people ... at the Otto Wagner Hospital// in Vienna enrolled 68 ... therapy, reported the online edition of health magazine WebMD. ... quitters enrolled in an exercise programme., ,The nicotine ...
... 44 researchers, including an Indian American scientist, have appealed ... charged// with intentionally infecting about 400 children with HIV.,Seeking ... doctor who have been incarcerated in a Libyan prison ... evidence shows the virus was present in the hospital ...
... breast cancer has led to confusion among women over what age ... ,Cancer Research UK said that most women erred in thinking the ... 70,. ,Their survey of 2,289 women revealed that 77 ... cancer was increased if she was under 70. Over a third ...
... a common crime with studies showing that around one in ... ,These shocking figures were compiled by the Gender ... ,Interviews of 1,370 males of ages of 15 to ... sexually violent behavior towards their spouse or other intimate partners, ...
... bra may reduce pain for women recovering from heart surgery. A ... in 10 cities across canada// . Dr. Kathryn King, in her ... significantly less post-surgical breast pain and discomfort, when ... ,Dr King submitted her findings to the Canadian Cardiovascular ...
... percent of patients showed evidence of a chronic ... new study measuring drug-induced liver// injury (DILI). Antimicrobials ... medications implicated in indiosyncratic DILI, according to data ... Induced Liver Injury Network (DILIN). The DILIN comprises ...
Cached Medicine News:Health News:Scientists Seek Release Of Health Workers In Libya 2Health News:Some Prescriptions Can Lead to Chronic Drug-Induced Liver Injury 2
Shielding's new Surgical Drop Away / Flex Back Apron offers top of the shoulder velcro flaps for an adjustable fit. Features elastic back panels for added comfort and support. For quick removal apron...
Shielding's Standard Coat Apron with open back allows for freedom of movement, maximum flexibility and increased comfort....
This set includes 2 small, 1 medium, 1 large gonad shields and a belt. The shields and belt is an interchangeable system attached by velcro....
Lap pad used to protect pelvic regions...
Medicine Products: